A Multimodal Intervention to Optimise Antimicrobial Use in Residential Aged Care Facilities (ENGAGEMENT Study) (ENGAGEMENT)

October 5, 2021 updated by: The University of Queensland

A Multimodal Intervention to Optimise Antimicrobial Use in Residential Aged Care Facilities (ENGAGEMENT Study): Protocol for a Stepped Wedge Cluster Randomised Trial

The antimicrobial stewardship ENGAGEMENT study aims to deliver a bundle of interventions, including education of GPs and nursing staff, guideline implementation and telehealth support for 18 residential aged care facilities (RACFs) in Queensland Australia to help optimise antibiotic prescribing and reduce inappropriate use. The trial will involve 18 licenced RACFs with 50 or more residents and is set to commence in June 2021.

Study Overview

Detailed Description

INTRODUCTION Inappropriate antibiotic use can cause harm and promote antimicrobial resistance, which has been declared a major health challenge by the World Health Organisation. In Australian Residential Aged Care Facilities (RACFs), the most common indications for antibiotic prescribing are for suspected infections of the urinary tract, respiratory tract, and skin and soft tissue. Studies indicate that a high proportion of these prescriptions are noncompliant with best prescribing guidelines. To date a variety of interventions have been reported to address inappropriate prescribing and overuse of antibiotics but with mixed outcomes. The present study aims to identify the impact of a set of sustainable, multi-modal interventions in residential aged care targeting three common infection types, using a robust methodology.

METHODS AND ANALYSIS This study will be conducted using a stepped-wedge cluster randomised trial that will recruit 18 RACFs (each RACF will be considered as one cluster), over a 20 month observation period. Initially an antimicrobial stewardship needs assessment toolkit will be piloted in seven RACFs from different service providers. This will enable the refinement and targeted implementation of the intervention bundle, based on existing requirement of facilities. A multimodal multi-disciplinary set of interventions, the 'ENGAGEMENT bundle', will be tailored to the needs of facilities. This bundle will be implemented as part of the stepped wedge randomised control trial. The key elements of the intervention bundle include education for nurses and general practitioners, telehealth support and formation of an antimicrobial stewardship team. Prior to the sequential introduction of the intervention, each site will act as its own control, in relation to usual care processes for antibiotic use and stewardship.

The primary outcome for this study will be antibiotic consumption measured using defined daily doses (DDDs). Cluster-level rates will be calculated using total occupied bed numbers within each RACF during the post-randomisation observation period as the denominator. Results will be expressed as rates per 1000 occupied bed days. An economic analysis will be conducted to compare the costs associated with the intervention to that of usual care.

Study Type

Interventional

Enrollment (Anticipated)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Queensland
      • Eight Mile Plains, Queensland, Australia, 4113
      • Mitchelton, Queensland, Australia, 4053
        • Recruiting
        • Carinity Aged Care
        • Contact:
          • Tunde Bulman
          • Phone Number: +61735503745
      • Rothwell, Queensland, Australia, 4022
      • Upper Mount Gravatt, Queensland, Australia, 4122

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Eligibility is at the Residential Aged Care Facility (RACF) level. If the facility is eligible to participate de-identified data from all facility residents will be included for the duration of the the study.

Inclusion Criteria:

  • All residents of RACFs with at least 50 residents
  • RACFs located in South East Queensland, Australia

Exclusion Criteria:

  • RACFs with less than 50 residents;
  • RACFs unable to provide reports for baseline data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ENGAGEMENT bundle
A multimodal bundle of interventions to optimise antibiotic prescribing in residential aged care facilities. The bundle includes education for nurses and general practitioners caring for residents, telehealth support and implementation of state-wide guidelines.

Given that a single intervention is unlikely to be effective in stewardship programs, nor in care improvement processes at RACFs [7], this trial will deliver a set of multimodal, multidisciplinary interventions to optimise antibiotic use in RACFs. This RACF AMS ENGAGEMENT bundle will comprise the following key interventions:

  • Education and engagement of prescribers, nurses, pharmacists and residents and family members
  • Nursing initiatives to improve UTI diagnosis and reduce inappropriate urine testing
  • Guideline development specific to antibiotic use in RACF residents
  • Antimicrobial stewardship team creation in RACF with GP involvement
  • EMergency department liaison and use of clinical pathways to ensure consistency of practice across the care continuum
  • ElectroNic decision support to guide RACF urine testing and GP antibiotic prescribing
  • Telehealth support for key intervention components
Placebo Comparator: Usual care
Usual facility practices with regards to antibiotic prescribing and review

Given that a single intervention is unlikely to be effective in stewardship programs, nor in care improvement processes at RACFs [7], this trial will deliver a set of multimodal, multidisciplinary interventions to optimise antibiotic use in RACFs. This RACF AMS ENGAGEMENT bundle will comprise the following key interventions:

  • Education and engagement of prescribers, nurses, pharmacists and residents and family members
  • Nursing initiatives to improve UTI diagnosis and reduce inappropriate urine testing
  • Guideline development specific to antibiotic use in RACF residents
  • Antimicrobial stewardship team creation in RACF with GP involvement
  • EMergency department liaison and use of clinical pathways to ensure consistency of practice across the care continuum
  • ElectroNic decision support to guide RACF urine testing and GP antibiotic prescribing
  • Telehealth support for key intervention components

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Defined Daily Doses (DDDs) of Antibiotics
Time Frame: 18 months
The primary outcome measure for this trial is antibiotic use as measured by DDDs of antibiotics per 1000 resident bed days.
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urine Samples
Time Frame: 18 months
Number of urine samples collected per 1000 resident bed days between the control vs intervention periods
18 months
Susceptibility of pathogens
Time Frame: 18 months
Percent susceptibility of Enterobacteriaceae to ceftriaxone, ciprofloxacin, cephalexin and amoxicillin-clavulanate measured using antibiograms
18 months
All cause on-year mortality
Time Frame: 18 months
All-cause on-year mortality rates of residential aged care facility (RACF) residents between the control vs intervention periods (per 1000 resident bed days and median rate across facilities)
18 months
Hospital admissions
Time Frame: 18 months
Number of RACF residents admitted to hospital during the control vs intervention periods (per 1000 resident bed days and median rate across facilities)
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Anticipated)

May 30, 2022

Study Completion (Anticipated)

December 24, 2022

Study Registration Dates

First Submitted

December 3, 2020

First Submitted That Met QC Criteria

January 11, 2021

First Posted (Actual)

January 12, 2021

Study Record Updates

Last Update Posted (Actual)

October 14, 2021

Last Update Submitted That Met QC Criteria

October 5, 2021

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020002193

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Antibiotics Causing Adverse Effects in Therapeutic Use

Clinical Trials on Antimicrobial Stewardship ENGAGEMENT bundle

3
Subscribe